Results 31 to 40 of about 198,691 (330)

Thrombolysis. [PDF]

open access: bronzeJournal of Clinical Pathology, 1972
A A, Sharp   +2 more
openaire   +4 more sources

MRI‐Guided Thrombolysis for Stroke with Unknown Time of Onset

open access: yesNew England Journal of Medicine, 2018
Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be ascertained that the time since the onset of symptoms was less than 4.5 hours.
G. Thomalla   +41 more
semanticscholar   +1 more source

Editor's choice : European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia

open access: yes, 2020
A
Acosta, Stefan   +33 more
core   +2 more sources

Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis [PDF]

open access: yes, 2007
Objective: To assess the cost effectiveness of primary angioplasty, compared with medical management with thrombolytic drugs, to achieve reperfusion after acute myocardial infarction ( AMI) from the perspective of the UK NHS.
Abrams, Keith   +6 more
core   +2 more sources

PRE-HOSPITAL THROMBOLYSIS IN KRASNOYARSK: RESULTS OF A RETROSPECTIVE COMPARATIVE STUDY

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To compare the safety and efficacy of pre-hospital thrombolysis with tenecteplase and hospital thrombolysis with alteplase. Material and Methods. Pre-hospital thrombolytic therapy with tenecteplase (n=15) and hospital thrombolysis with alteplaza (n ...
S. A. Skripkin   +4 more
doaj   +1 more source

Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register [PDF]

open access: yes, 2017
Purpose: Beyond intravenous thrombolysis, evidence is lacking on acute treatment of minor stroke caused by large artery occlusion. To identify candidates for additional endovascular therapy, we aimed to determine the frequency of non-haemorrhagic ...
Ahmed, Niaz   +11 more
core   +1 more source

Tenecteplase Thrombolysis for Acute Ischemic Stroke.

open access: yesStroke, 2020
Tenecteplase is a fibrinolytic drug with higher fibrin specificity and longer half-life than the standard stroke thrombolytic, alteplase, permitting the convenience of single bolus administration.
S. Warach, A. Dula, T. Milling
semanticscholar   +1 more source

Ekosonic Endovascular System (EKOS) in a trauma patient with intracranial bleed, recent major surgery, and massive pulmonary embolus: A case report

open access: yesRadiology Case Reports, 2018
Pulmonary embolism is a life-threatening condition treated with anticoagulation and systemic thrombolysis when appropriate. In patients with contraindications to thrombolysis, catheter-directed thrombolysis may be considered.
Steve M. Nelson, MD, Steven H. Craig, MD
doaj   +1 more source

Spectrophotometric analysis of thrombolytic activity: SATA assay [PDF]

open access: yes, 2017
Introduction: Measurement of thrombolytic activity i.e. clot lysis is crucial for research and development of novel thrombolytics. It is also a key factor in assessment of the effectiveness of conventionally used thrombolytic agents in the clinic, which ...
Entekhabi, Nazila   +5 more
core   +2 more sources

Saudi neurology residents' knowledge and attitudes toward intravenous thrombolysis in patients with acute ischemic stroke

open access: yesJournal of Family Medicine and Primary Care, 2020
Background: Although intravenous (IV) thrombolysis is an effective treatment for patients with acute ischemic stroke (AIS), it remains underused by neurologists worldwide. This study assessed the knowledge and attitudes toward IV thrombolysis in patients
Fatimah Ali Alharbi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy